Efficacy and safety of omalizumab for children and adolescents with atopic dermatitis (Literature review)
Year: 2025
Type: article
Source: Glavvrač (Chief Medical Officer)
Authors: K. O. Shnaider, A. P. Kondrakhin, M. L. Maksimov, A. S. Belokopytov, Yu. E. Smirnova, A. N. Babichev, B. U. Gibadatov
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413447128
